Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Cimiside E has anti-inflammatory activity, it selectively inhibits TNF-α-induced expression of VCAM-1 at least by upregulation of PPAR-γ, and signals for ERK1/2, PI3K, and PKC are involved in this effect.Cimiside E may be an effective chemopreventive agent against cancer, it arrests cell cycle and induces cell Apoptosis in gastric cancer cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Cimiside E has anti-inflammatory activity, it selectively inhibits TNF-α-induced expression of VCAM-1 at least by upregulation of PPAR-γ, and signals for ERK1/2, PI3K, and PKC are involved in this effect.Cimiside E may be an effective chemopreventive agent against cancer, it arrests cell cycle and induces cell apoptosis in gastric cancer cells. |
Source |
Molecular Weight | 602.809 |
Formula | C35H54O8 |
CAS No. | 154822-57-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cimiside E 154822-57-8 Apoptosis Chromatin/Epigenetic Cytoskeletal Signaling DNA Damage/DNA Repair Immunology/Inflammation MAPK Metabolism PI3K/Akt/mTOR signaling ERK Akt TNF ROS PI3K PKC PPAR inhibitor inhibit